Мы используем Cookies Этот веб-сайт использует cookie-файлы, чтобы предлагать вам наиболее актуальную информацию. Просматривая этот веб-сайт, Вы принимаете cookie-файлы.
Background: Papillary thyroid carcinoma often has lymph node metastasis, compared with follicularthyroidcarcinoma.
2
The differential diagnostic of follicular thyroid adenomas and follicularthyroidcarcinoma is a notorious challenge for pathologists.
3
This was substantiated by the demonstration that pre-miR-199b reduced proliferation when added to cultured follicularthyroidcarcinoma cells.
4
About 10% of follicularthyroidcarcinoma shows multiple metastases: lung and bone are the most common sites of metastasis.
5
A case of multiple, functional bone metastases from a previously operated follicularthyroidcarcinoma is reported in an apparently euthyroid patient.
1
No negative test result is conclusive for ruling out the possibility of follicularcarcinoma.
2
Therefore the differentiation between PAP and follicularcarcinoma is essential.
3
Lessons: We should differentially diagnose the renal metastasis of thyroid follicularcarcinoma or papillary carcinoma.
4
A biopsy of the rib confirmed the presence of metastatic follicularcarcinoma of the thyroid.
5
There were seven papillary carcinomas and one follicularcarcinoma.
Использование термина follicular thyroid cancer на английском
1
Thus, the value of octreotide as an antitumoral agent in follicularthyroidcancer must be critically questioned.
2
In conclusion, octreotide at low concentrations stimulates and at high concentrations inhibits the growth and invasion of follicularthyroidcancer cells in culture.
3
Patients and methods: We present the case of a 67-year-old woman, undergoing total thyroidectomy for follicularthyroidcancer with bone and lung metastasis.
4
Octreotide had also a dose-dependent biphasic effect on the invasion of FTC, inhibiting the invasion of all follicularthyroidcancer lines at high concentrations.
5
Of these patients, 24 had papillary thyroid cancer, 2 had follicularthyroidcancer, and 11 had Hurthle cell thyroid cancer.
6
Results: The 21 patients accounted for 0.33% of all 6308 patients, including twenty cases of papillary thyroid carcinoma and one case of follicularthyroidcancer.
7
The initial risk stratification has been completed, especially precising the risk of N1 patients, follicularthyroidcancers, and the prognostic impact of molecular markers.